Are we underestimating the clinical efficacy of botulinum toxin (type A)? Quantifying changes in spasticity, strength and upper limb function after injections of Botox® to the elbow flexors in a unilateral stroke population

Clinical Rehabilitation

Volumn 16, Issue 6, 2002, Pages 654-660

  Pandyan, Anand D ^a   Vuadens, Philippe ^b   van Wijck, Frederike M J ^c   Stark, Sandra ^d   Johnson, Garth R ^e   Barnes, Michael P ^e  

^a KEELE UNIVERSITY   (United Kingdom)

^b SUVA   (Switzerland)

^c UNIVERSITY OF NEWCASTLE   (Australia)

^d Hunters Moor Regional Rehabilitation Centre   (United Kingdom)

^e NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A;

ARM MOVEMENT; ARTICLE; BICEPS BRACHII MUSCLE; BRACHIORADIALIS MUSCLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; ELBOW; ELECTROMYOGRAPHY; FEMALE; FLEXOR DIGITORUM LONGUS MUSCLE; FLEXOR MUSCLE; FUNCTIONAL ASSESSMENT; GRIP STRENGTH; HUMAN; LONGITUDINAL STUDY; MALE; MOTOR CONTROL; MUSCLE FORCE; MUSCLE ISOMETRIC CONTRACTION; MUSCLE STRENGTH; MUSCLE WEAKNESS; QUANTITATIVE ANALYSIS; RATING SCALE; SPASTICITY; STROKE;

ADULT; BOTULINUM TOXIN TYPE A; CEREBROVASCULAR ACCIDENT; ELBOW; ELECTROMYOGRAPHY; HAND STRENGTH; HUMANS; INJECTIONS; LONGITUDINAL STUDIES; MUSCLE CONTRACTION; MUSCLE SPASTICITY; MUSCLE, SKELETAL; NEUROMUSCULAR AGENTS; RECOVERY OF FUNCTION; UPPER EXTREMITY;

EID: 0036744479     PISSN: 02692155     EISSN: None     Source Type: Journal    
DOI: 10.1191/0269215502cr536oa     Document Type: Article

References (20)

1. Barnes MP, Ward AB. Textbook of rehabilitation medicine. Oxford: Oxford University Press, 2000.
2. Isard PA, Forbes JF. The cost of stroke to the National Health Service in Scotland. Cerebrovasc Dis 1992; 2: 47-50.
3. Lance JW. Pathophysiology of spasticity and clinical experience with Baclofen. In: Lance JW, Feldman RG, Young RR, Koella WP eds. Spasticity: disordered motor control. Chicago: Year Book, 1980: 185-204.
4. Barnes MP. An overview of the clinical management of spasticity. In: Barnes MP and Johnson GR eds. Upper motor neurone syndrome and spasticity: clinical management and neurophysiology. Cambridge: Cambridge University Press, 2001: 1-11.
5. Twitchell TE. The restoration of motor function following hemiplegia in man. Brain 1951; 74: 443-80.
6. Gray GS, French JM, Bates D et al. Motor recovery following stroke. Age Ageing 1990; 19: 179-84.
7. Pandyan AD, Price CIM, Rodgers H et al. A clinical tool to measure resistance to passive movement: a biomechanical alternative to the clinical grading of spasticity. Paper presented to the summer meeting of the Society for Research in Rehabilitation, July 2000, Liverpool, UK.
8. Davis EC, Barnes MP. The use of botulinum toxin in spasticity. In: Barnes MP, Johnson GR eds. Upper motor neurone syndrome and spasticity: clinical management and neurophysiology. Cambridge: Cambridge University Press, 2001: 206-22.
9. Simpson DM, Alexander DN, O'Brien CF et al. Botulinum toxin type A in the treatment of upper extremity spasticity: a randomized, double-blind, placebo-controlled trial. Neurology 1996; 46: 1306-10.
10. Bakheit AMO, Thilman AF, Ward AB et al. A randomized double-blind, placebo-controlled, dose-ranging study to compare the efficacy and safety of three doses of botulinum toxin type A (Dysport) with placebo in upper limb spasticity after stroke. Stroke 2000: 2402-406.
11. Smith SJ, Ellis E, White S et al. A double-blind placebo-controlled study of botulinum toxin in upper limb spasticity after stroke or head injury. Clin Rehabil 2000; 14: 5-13.
12. Richardson D, Sheean G, Werring D et al. Evaluating the role of botulinum toxin in the management of focal hypertonia in adults. J Neurol Neurosurg Psychiatry 2000; 69: 499-506.
13. Bohannon RW, Smith MB. Inter rater reliability of a modified Ashworth scale of muscle spasticity. Phys Ther 1987; 67: 206-207.
14. Ashworth B. Preliminary trial of carisoprodal in multiple sclerosis. Practitioner 1964; 192: 540-42.
15. Pandyan AD, Price CIM, Curless RH et al. A review of the properties and limitations of the Ashworth and modified Ashworth Scales. Clin Rehabil 1999; 13: 373-83.
16. Lyle RC. A performance test for assessment of upper limb function in physical rehabilitation treatment and research. Int J Rehabil Res 1981; 4: 483-92.
17. Brin MF et al. Dosing, administration, and a treatment algorithm for use of botulinum toxin A for adult onset spasticity. Muscle Nerve 1997; s6: s208-s220.
18. Bernstein N. The problem of the interrelation of co-ordination and localization. Arch Biol Sci 1935; 38 (This paper is reproduced in HTA Whiting ed. Human motor actions - Bernstein reassessed. Amsterdam: North Holland, 1984; 77-119. ISBN 0 444 86813 5).
19. Bailar III JC. The powerful placebo and the Wizard of Oz. N Engl J Med 2001; 344: 1630-32.
20. Hrobjartsson A, Gotzscge PC. Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment. N Engl J Med 2001; 344: 1594-602.